<DOC>
	<DOC>NCT02299310</DOC>
	<brief_summary>The purpose of this study is to compare the effect of valsartan and perindopril on HOMA-IR Index in patients with chronic kidney disease.</brief_summary>
	<brief_title>Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease</brief_title>
	<detailed_description>eligiable volunteers are administrated single-dose over the period I and II (crossover) of Valsartan (80mg) as of Perindopril (4mg). Every time before and after each medication, HOMA-IR index and other parameters and safety of Valsartan (80mg) and Perindopril (4mg) is performed using a blood sample and conducting some tests (vital signs, physical exam, ECG, laboratory test, etc.) respectively.</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Perindopril</mesh_term>
	<criteria>Clinical diagnosis of chronic kidney disease Serum creatinine:1~3mg/dl Diabetes Patients treated with corticosteroids or immunosuppressants BMI&gt;30kg/m2 SP&gt;180mmHg, DP&gt;110mmHg Patients with serious medical problems requiring specific medical treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Chronic kidney disease, Anti-hypertensive drugs</keyword>
</DOC>